What is the appropriate management for a 41-year-old woman with menorrhagia, leukopenia, microcytosis, low mean corpuscular hemoglobin, normal platelet count, and low‑normal ferritin?

Management Recommendation

This patient has iron deficiency (ID) despite a hemoglobin level that appears "normal" at 12.3 g/dL, and requires immediate iron supplementation and treatment of her menorrhagia to prevent progression to severe anemia. 1, 2

Key Laboratory Interpretation

Your patient's labs reveal:

• Microcytic anemia (MCV 77.9, MCH 23.8, MCHC 30.6) - all significantly reduced
• Ferritin 60 ng/mL - This appears "normal" but is actually diagnostic of iron deficiency in the context of her microcytosis and menorrhagia
• Hemoglobin 12.3 g/dL - Just at the WHO threshold for anemia in women (<12 g/dL), but the microcytosis indicates established iron deficiency 2

Critical point: The 2024 AGA guidelines recommend using a ferritin cutoff of 45 μg/L (ng/mL) for diagnosing iron deficiency in anemic patients, as this provides optimal sensitivity/specificity balance 1. The 2021 British Society of Gastroenterology guidelines similarly note that ferritin <45 μg/L warrants investigation and treatment, with specificity of 0.92 for iron deficiency 2. Your patient's ferritin of 60, while technically "normal," is low-normal in the setting of clear microcytic indices, indicating depleted iron stores that have already affected red cell production.

Immediate Management Algorithm

1. Iron Replacement Therapy - Start Now

Initiate oral iron supplementation immediately:

• Ferrous sulfate, ferrous fumarate, or ferrous gluconate (least expensive, equally effective) 1
• Take on empty stomach if tolerated; if not, take with meals containing meat protein 1
• Add 500 mg vitamin C to enhance absorption 1
• Goal: Replete iron stores and prevent progression to severe anemia

If oral iron fails after 4 weeks (no improvement in hemoglobin/ferritin) or is not tolerated due to GI side effects, switch to intravenous iron 1, 3

2. Treat the Menorrhagia - Address the Root Cause

First-line medical management options:

• Tranexamic acid 3.9 g/day (1.3 g orally up to 3x daily for 5 days per menstrual cycle) - proven to increase hemoglobin and ferritin levels in women with heavy menstrual bleeding 4
• Hormonal therapy: Combined oral contraceptives or progestins (medroxyprogesterone)
• NSAIDs (prostaglandin inhibitors) during menses 5

The combination of iron supplementation AND menorrhagia treatment is essential - treating iron deficiency alone without controlling blood loss will result in recurrent deficiency 4, 6

3. Address the Leukopenia (WBC 3.4)

The mild leukopenia requires evaluation:

• Review medications (especially psychotropics that can cause both leukopenia and menorrhagia) 5
• Consider nutritional deficiencies (B12, folate) that may coexist
• If persistent or worsening, consider hematology referral to rule out bone marrow pathology

However, do not delay iron and menorrhagia treatment while investigating the leukopenia - the iron deficiency is established and requires immediate attention.

Critical Pitfalls to Avoid

1. Don't be falsely reassured by "normal" hemoglobin of 12.3 g/dL - The microcytosis (MCV 77.9) indicates this patient has been iron deficient long enough to affect red cell production. Women have presented with hemoglobin <5 g/dL from chronic menorrhagia because they and their providers normalized the bleeding 7

2. Don't wait for ferritin to drop below 30 or 15 - Current guidelines recognize that ferritin <45 in the setting of microcytosis warrants treatment 1, 2. Waiting for more severe deficiency risks progression to symptomatic anemia.

3. Don't treat iron deficiency without addressing menorrhagia - More than 40% of women with menorrhagia-related severe anemia had received previous transfusions but no definitive bleeding treatment, leading to recurrent crises 7. The bleeding must be controlled.

4. Don't assume the patient recognizes the severity - Studies show that even women with life-threatening anemia (Hgb <5 g/dL) from menorrhagia often describe their bleeding as "normal" or delay seeking care for >6 months 7. Proactive physician intervention is essential.

Follow-Up Monitoring

• Recheck CBC and ferritin in 4 weeks to assess response to oral iron 3
• If no improvement: switch to IV iron and ensure menorrhagia treatment compliance
• Target ferritin >30 μg/L minimum, ideally >50-100 μg/L to build adequate stores
• Continue iron supplementation until ferritin normalized and menorrhagia controlled

Why This Matters for Quality of Life

Iron deficiency, even without severe anemia, causes:

• Cognitive dysfunction and impaired work/school performance 6
• Fatigue and reduced quality of life 1, 6
• In pregnancy, potential adverse fetal neurodevelopment 6

Your patient is at risk for progression to severe anemia if menorrhagia continues untreated - women have presented with hemoglobin levels as low as 1.6 g/dL from chronic menstrual blood loss 7.